University of Colorado

Denver, Colorado 80309

14 studies enrolling now · 178 studies all time

What they study most

ALS, Accelerated Phase Chronic Myelogenous Leukemia, Accelerated Phase of Disease, Acute Biphenotypic Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Acute Respiratory Failure, Adenocarcinoma of the Pancreas

Studies at this site

• A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD — Recruiting now
• DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Recruiting now
• Characterization and Treatment of Adolescent Depression — Recruiting now
• Adjustable Continence Therapy (ACT) for the Treatment of Female SUI — Recruiting now
• A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma — Recruiting now
• A Global Study of the PETAL Consortium — Recruiting now
• Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study — Recruiting now
• Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study — Recruiting now
• Study of Biomarker-Based Treatment of Acute Myeloid Leukemia — Recruiting now
• Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY — Recruiting now
• Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study — Recruiting now
• American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry — Recruiting now
• ProACT Post-Approval Study — Recruiting now
• PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD. — Recruiting now
• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy — Stopped early
• Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer — Running, not enrolling
• Phase 1/2 Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) — Completed
• Study of INBRX-109 in Conventional Chondrosarcoma — Running, not enrolling
• Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) — Running, not enrolling
• Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma — Running, not enrolling
• Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS) — Completed
• A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix — Completed
• Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer — Completed
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery — Completed
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• RADIQAL Study (Radiation Dose and Image Quality Trial) — Running, not enrolling
• Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer — Completed
• Chronic Pain in Rheumatoid Arthritis — Running, not enrolling
• A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer — Stopped early
• Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies — Enrolling by invitation
• Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors — Stopped early
• Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant — Completed
• Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study — Running, not enrolling
• Effects of Pazopanib on Hereditary Hemorrhagic Telangiectasia Related Epistaxis and Anemia (Paz) — Running, not enrolling
• Long-Term Follow-up Study — Enrolling by invitation
• Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients — Completed
• Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial — Running, not enrolling
• A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes — Completed
• A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. — Completed
• Global Study of Del-desiran for the Treatment of DM1 — Running, not enrolling
• Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer — Running, not enrolling
• Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors — Running, not enrolling
• A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301) — Completed
• Study of the Safety and Efficacy of Ulipristal Acetate (UPA) Used Daily as a Contraceptive — Withdrawn before enrolling
• Study Comparing Emergency Contraception Effectiveness in Women Who Weight ≥ 80 kg — Stopped early
• KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis — Running, not enrolling
• Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma — Stopped early
• Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients — Completed
• A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer — Running, not enrolling